Several groups have molecularly characterised aspects of CRPM and found that tumours appear increasingly homogenous and categorise as an aggressive highly angiogenic mesenchymal phenotype (consensus molecular subtype, CMS 4).24, 27. Here, SH3BP2 is linked to neoplasm.